HCPLive
@HCPLiveNews
Followers
7,469
Following
1,016
Media
10,990
Statuses
52,924
Everything you need to enhance your clinical approach to improving patient care.
United States
Joined January 2009
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
NACIONAL NACIONAL
• 316757 Tweets
#GranHermano
• 144215 Tweets
スタンプ
• 138197 Tweets
GPT-4o
• 104502 Tweets
#JACKANDJOKERQ1
• 95694 Tweets
#WWERaw
• 83379 Tweets
Rangers
• 54370 Tweets
Luciano
• 39660 Tweets
Dallas
• 39095 Tweets
Cavs
• 37484 Tweets
Thunder
• 36866 Tweets
#साथी_मुहिम
• 28718 Tweets
Diniz
• 26107 Tweets
Mavs
• 20864 Tweets
Dort
• 20224 Tweets
Canes
• 19816 Tweets
Gunther
• 17702 Tweets
Shai
• 16068 Tweets
Dario
• 15509 Tweets
スナック
• 13739 Tweets
スクエニ
• 12738 Tweets
Jey Uso
• 11728 Tweets
Daronco
• 11262 Tweets
Social media plays a big role in medicine, says
@DrKevinCampbell
. Just look at what it did at
@AHAMeetings
!
#AHA16
1
16
24
You heard it from
@DrKevinCampbell
! The PIONEER trial is a potential "game changer" in cardiac health:
#AHA16
0
11
8
Beware of football practices, scrimmages, and games:
0
1
2
Shout out to
@SuhaAbushamma
, winner of the ACG Question of the Week, recipient of a free trip to Vancouver and the chance to enjoy the beautiful Capilano suspension bridge. Great resource for all those studying for GI boards
#ACG2023
- Posted by
@KatieFalloonMD
0
7
34
"My hope is that the trial results of REDUCE-IT will be viewed as practice-changing."
-
@DLBHATTMD
2
10
30
New Tech Laws Equal Doctors Glued to Computers—And Patients Are Squeezed Out - via
@Shareaholic
0
0
1
0
3
1
"What is fact is that the gut microbiome is key in
#allergy
prevention and allergy management. I think the other fact is that we do not know what to manipulate, and we do not know how to manipulate it."
-
@VenterCarina
at
#ACAAI19
2
10
28
At the end of a conversation about
#ACC20
with
@RealPatCampbell
,
@DLBHATTMD
concluded with a brief sentiment on the COVID-19 pandemic—wishing luck to his colleagues and clinicians as they confront the ever-growing issue.
@BrighamWomens
1
8
27
"They'd rather not have a
#stroke
after MI or a CV death after an episode of unstable angina. So, from a patient-centered perspective, perhaps the total events is really the more appropriate way of looking at data."
-
@DLBHATTMD
on REDUCE-IT findings
0
9
24
Honored to be working with you!
Fantastic to work with
@MDMagazine
during
#aha16
Here are my thoughts and reflections on
#SocialMedia
and medicine
0
9
9
1
1
5
“Like many of you, I see patients every day. And this will change what you do Wednesday morning when you’re back at work.”
The powerful findings of icosapent in REDUCE-IT:
0
9
27
Cardiovascular biomarkers have played a big part in terms of patients admitted with
#COVID19
.
@DLBHATTMD
@CMichaelGibson
0
13
22
Might there be a possible role for atovaquone in patients with IBD? Find out more from
@AhmedNadeemMD
1
4
27
Physician burnout and stress have grown rampant across the world of medicine. What are some of the practices doctors, universities, and health care leaders use to fight them?
#Burnout
0
12
24
Today, Dr. Anita Reddy of
@ClevelandClinic
presented data at
#CCC48
showing reduced chest X-rays in the ICU could benefit patients. Read our conversation with her here:
0
14
23
"The main goal for treating patients with AF is to prevent
#stroke
from occurring.” - study researchers said:
0
3
4
Patients with refractory colitis respond to biological therapy but few achieved histologic remission in this retrospective study by
@PriSantiagoMD
@VictorChedidMD
@ManuelBragaMD
0
5
25
Bad news for soda lovers! Frequent consumption raises the risk for prediabetes:
1
6
3
Check out our latest video discussion on
#HeartFailure
featuring
@JavedButler1
@jjheart_doc
,
@mvaduganathan
and
@robmentz
:
2
10
22
Should we be performing subtotal colectomies in IBD PSC patients and is the risk comparable to IPAA? Come check out ⭐️and fellow Katie’s poster to find out
@dunleavy_katie
#DDW2023
-
@KatieFalloonMD
0
5
24
"We have a fantastic bunch of traditional cardiologists who've run those units fantastically well over the last few decades, but now I think we need new people with new intensive skills."
@venumenon10
of
@ClevelandClinic
shares cardio perspective:
0
11
23
In light of national discussions following the
#Dayton
&
#ElPaso
shootings, this week's
#DocTalk
tweet chat (Tuesday, 9 PM EST) will address mental health stigma, led by
@drjessigold
,
@amybarnhorst
, and
@DrHowardLiu
. Please join us.
2
13
21
Next time,
@KatieFalloonMD
writes a fascinating article about extra-intestinal manifestations in patients with
#IBD
.
1
5
22
What are the risks of asymptomatic clots, compared to symptomatic? Insights from
@DLBHATTMD
,
@CMichaelGibson
,
@GaryRaskob
, and more:
1
5
17
"While we wait for formal guidelines… it is important for health care professionals who treat infants to understand the rapidly evolving evidence surrounding early introduction of allergenic foods," said
@AllergyKidsDoc
2
17
21
Cardiac specialist from
@ClevelandClinic
talks heart attacks in seemingly healthy, fit people:
0
19
16
3
23
21
Stay tuned on our
#AHA16
conference page here:
I will have another video summary w/
@MDMagazine
this afternoon after today's science is presented
#aha16
Enjoy the day
@AHAMeetings
1
5
13
0
2
3
#DocTalk
is back tomorrow, 6 PM EST, with
@StacyBrethauer
. The
@OSUWexMed
surgeon and past
@ASMBS
President will be leading discussion on obesity, bariatric surgery, and interpreting BMI. Here's the details:
2
5
18
"It feels like this momentum...this movement of people that don't feel alone in sharing these stories, because it is so common. We just needed to lift the blindfold off and look around, and realize that we're all in this together."
-
@Adamhill1212
0
6
15
At
#HID22
,
@ProfKausikRay
discusses the effect of current practice on cholesterol goal attainment and role of combination therapy to help better control LDL-C levels.
0
8
19
The
@MilestoneIBD
program is an incredible yearlong program for advanced IBD fellows that I loved participating in this year! Check out this poster for data highlighting satisfaction with the program and impact on knowledge -
@KatieFalloonMD
#DDW2023
@IBDBen
0
5
19
Just finished attending an amazing ACG PR Committee meeting with ⭐️⭐️outgoing chair
@ibdtweets
and ⭐️⭐️incoming chair
@ReezwanaCMD
What an exciting year ahead! And of course looking forward to
#ACG2023
#IRL
and Scopy Awards tonight
-
@KatieFalloonMD
1
3
19
Expert clinicians discuss the prevalence and overall burden of sickle cell disease across the globe and recognize the role of community physicians in managing the disease.
#SickleCell
@ifyosunkwomd
0
8
17
Check out this interview with
@MasriAhmadMD
at
#ACC2023
where he provides further insight into the results of the REDWOOD-HCM cohort 4, which included 41 patients with non-obstructive hypertrophic cardiomyopathy.
#Cardiology
#HCM
0
4
17
A virtual care team-guided strategy improved GDMT use among patients hospitalized with HFrEF in the IMPLEMENT-HF trial.
We spoke with
@ankeetbhatt
at
#ACC23
to learn more:
#HeartFailure
#cardiology
0
6
17
Hear
@RobMentz
and
@JavedButler1
comment on the use of beta blockers and other agents in patients with heart failure preserved ejection fraction.
#HFpEF
0
3
17
Trying to predict post-operative ✂️ outcomes in older ibd patients? Choose skeletal muscle over psoas muscle found
@AdamFayeMD
#DDW2023
-
@KatieFalloonMD
1
5
18
Majority of first-year residents' time is spent performing indirect patient care, accounting for nearly 16 hours of a 24-hour period while direct patient care accounts for just 3 hours of that same period.
#medicalschool
#lifeofamedstudent
0
6
14
The
#FDA
has approved icosapent ethyl (Vascepa) as an adjunctive therapy for CV risk reduction, off the strength of the REDUCE-IT findings.
Live coverage, with earlier insight from
@DLBHATTMD
0
8
17
Wondering about AI applications? 💻 Check out this poster by the incredible
@silverman_anna
and colleagues!
#ACG2023
2
3
18
Throwback to yesterday evening -
@cmaruggi
was a 💪
#EndoTitan
competitor 💩
#ACG2023
@ClevelandClinic
0
5
18
WATCH:
@ErinMichos
leads a discussion on selecting the appropriate patient populations for the use of bempedoic acid when managing
#ASCVD
and
#hypercholesterolemia
.
Link here:
0
4
17
Discussing social media and the FDA in Forbes...
0
5
6
0
2
3
@KatieFalloonMD
here, starting my HCP Live takeover 👋 Currently at a packed IBD session moderated by
@MRegueiroMD
and
@Realcecum
leaning practical evidence based tips on role of diet for IBD from Dr. Ananthakrishnan
#DDW2023
@tqaziMD
@IBDBen
0
6
17
From our
#cardiology
panel featuring
@DLBHATTMD
,
@CMichaelGibson
,
@GaryRaskob
, and Dr. Piazza: Identifying System Level Risk Measurement and Risk Scores.
0
6
13
.
@DLBHATTMD
, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital and professor of medicine at Harvard Medical School, discusses potential advances in cardiology that excite him most.
0
7
15
1
3
3
0
2
2
"The bottom line is, yes, treat patients appropriately with their myocardial infarction with revascularization. But, irrespective of that background therapy, there's still a benefit of icosapent ethyl over placebo." -
@DLBHATTMD
#ESCCongress
0
4
15
The prospect of sotagliflozin as an SGLT1/2 inhibitor in heart failure has cardiologists buzzing. Stay informed on the latest developments and potential implications for heart failure management.
#HeartFailure
0
9
15
It's official,
#AHA16
is in full swing! Here are the studies you should look out for, says
@DrKevinCampbell
:
1
7
6
"We have flipped the script on these families. All of a sudden we are turning this poison into a medicine, right? And I think that is something that is completely foreign to them."
-
@DrDougMackMD
on training parents in immunotherapy at
#ACAAI19
0
5
14
0
0
15
Hello,
@KatieFalloonMD
here back for Twitter takeover round 2. Starting the afternoon taking advantage of another opportunity to see IUS ⭐️s
@DrMikeDolinger
and
@KrugCleveland
in action. Exciting new frontier in the world of IBD!
#DDW2023
@iUSCAN
0
5
14
0
4
3
Learn more about effects of icosapent ethyl (Vascepa) in diabetic patients by checking out our interview with
@DLBHATTMD
as we discuss REDUCE-IT DIABETES from
#ADA2020
.
#ADAGoesVirtual
0
6
14
Another of the highlights of ACG for me is the opportunity for collaboration and mentorship - the ACG Mentoring program is a great opportunity for all. Proud of these three ⭐️ mentees
@ZahraDossaji
,
@Montalvan214
and
@MudePooja
#ACG2023
-
@KatieFalloonMD
0
6
14
Welcome to this week's
#DocTalk
#SoMeDocs
chat, "Doctors Getting Online," hosted by
@DrCorriel
!
Please take a minute to introduce yourself before the questions begin.
@somedocs
#medtwitter
7
4
13
In
@OchsnerHealth
's Optimal Hospital initiative, a key feature for patient empowerment is the iPad each patient receives that gives them access to their own medical records and their upcoming tests and procedures.
1
3
13
"The concern about vaccines is that it does seem like the time to a vaccine, in part, is dependent on how many people you test it in for how long."
#COVID19
@DLBHATTMD
@CMichaelGibson
0
2
8
Above all the titles
@CMattocks1
has held in his career, he champions the role of
#healthcare
advocate. What is he doing to bring direct access to patients in need?
5
13
14
The
@BillGates
& Melinda Gates Foundation granted $89 million to the outside costs of the clinical trial for the
@NovavaxInc
investigative respiratory syncytial virus (RSV) vaccine in third-trimester pregnant women.
0
3
13
"You must be prepared to let them know what happens next because you're going to come across people who had lung cancer screening and will present some sabotage planning not to pursue it,"
@panagis21
explains.
#ATS2023
@atscommunity
@HopkinsMedicine
3
3
13
Our cardio followers are in for a treat this week. Late last week,
@DLBHATTMD
stopped by our studios and talked everything PCSK9 agents, to heart disease, and the REDUCE-IT trials with
@RealPatCampbell
.
Check back throughout the week for video coverage from the interview.
0
5
12
Exciting work looking at machine learning 💻📈 in the prediction of IBD
@DocCohenIBD
@EmmaChancellor
@IBD_FloMD
0
3
13
“On top of all those good things, even if the LDL is well controlled, there's still a substantial benefit of icosapent ethyl versus placebo in this trial. Even if you're doing everything you should for patients, this is an added benefit.”
#ESCCongress
0
6
13
Ok last tweet, my talk about Emerging Treatments for
#Vitiligo
! Opzelura was FDA-approved last summer, first for vitiligo. Ongoing trials testing oral JAK inhibitors include ritlecitinib (phase 3) and upaticitinib (phase 2)
1
1
13
Our first
#DocTalk
tweet chat, "The State of Drug Shortages in the US," is scheduled for this Wednesday at 1:30 PM EST.
We're proud to announce
@DrHowieMell
,
@ACEPheadliner
, and
@ActuallyDrJ
as our co-hosts!
0
11
13
New data from
@RushMedical
indicates increased consumption of flavonols—an antioxidant common in fruits, vegetables, and teas—was linked to decreased risk of Alzheimer
#dementia
in older adults.
#Alzheimer
#Geriatrics
@GreenJournal
0
4
13
A new study from
@DLBHATTMD
@rkwadhera
found the annual top-50 hospital ranking from
@USNewsHealth
is a reliable indicator of cardiovascular disease mortality and patient satisfaction:
0
4
12
.
@Amarincorp
announced the US FDA has granted priority review for Vascepa's sNDA for the reduction of residual cardiovascular risk in patients with statin-managed LDL-C cholesterol, but persistent elevated triglycerides.
0
7
13
In a new interview,
@DrRobertKushner
emphasizes the importance of weight management in mitigating cardiovascular risk in patients with obesity.
#ASPC2022
0
5
11
In this video,
@dranulala
discusses the challenges in managing heart failure in the United States as well as the universal definition of heart failure and classification by left ventricle EF:
0
6
13
Dapagliflozin (
#Farxiga
) has received approval for the reduction of risk of hospitalization for heart failure in patients with type 2 diabetes.
#dapagliflozin
#Diabetes
0
7
12
New video segment:
@JavedButler1
and colleagues discuss future directions for
#oHCM
treatment. Watch here:
0
2
12
It's almost time for Dr. Falloon's takeover during the
#ACG2023
poster sessions today! Be sure to follow us and Dr. Falloon (
@KatieFalloonMD
) throughout all the action this afternoon!
@NotADoctorKevin
@SilasInman
Also, a little bit of mid-meeting fun:
@KatieFalloonMD
will be taking over our account on Monday 10/23 to walk through the
#ACG2023
poster hall and discuss an afternoon lecture!
Be sure to follow us and Dr. Falloon leading up to the all the coverage beginning Sunday!
0
4
8
0
6
13
A recent study led by
@abdtahrani
found weight loss surgery led to a 30% lower risk of all-cause mortality, a 43% lower risk of
#HeartFailure
, and a 59% lower risk of
#hypertension
in a cohort of more than 15,000 obese patients.
@qehbham
#Cardiotwitter
1
7
13
Are you screening for gynecologic symptoms in your GI patients? Learn from
@DrMadisonSimons
why you should!
#ACG2023
@ClevelandClinic
- posted by
@KatieFalloonMD
0
10
14
While statins remain standard of care, approval of bempedoic acid and bempedoic acid/ezitimibe appears—at least on paper—to threaten the role of PCKS9 inhibitors in treatment algorithms.
We spoke to
@DLBHATTMD
for his take on LDL-C lowering in 2020.
1
2
12
Sold-out MTE session on spatial and single cell omics at
#TLM23
. Drs.
@prakramacha
@SammiShuang
leading the session!
-
@EKostallari_PhD
0
4
13
Read what
@paller_lab
and fellow investigators encountered in their investigation of dupilumab-associated
#psoriasiform
lesions in
#pediatric
patients
0
3
10
Presented at
@WCIRDC
today: new recommendations from a multi-specialty task force that addresses patients with cardiorenal, diabetic, and metabolic disease.
Read more here:
0
8
12
At 6 months, the SpyGlass drug delivery platform continued to demonstrate a 45% reduction in mean intraocular pressure in a First-in-Human
#glaucoma
treatment trial.
Check out a new interview with
@MalikKahook
on the exciting results.
1
5
12
Last week, we launched the first segments in our Peer Exchange on
#IgANephropathy
with
@IgAN_JBarratt
@SethiRenalPath
,
@anuja_java
and more!
Check it out using the link below:
#Kidney
#Nephrology
0
6
11
#Sarcoidosis
is a chronic disease that disproportionately affects African American women.
Expert
@obi_ogugua
explains why in an in-depth interview with
@GiulianaGrossi
#IgnoreNoMore
#InternationalWomensDay
#WomensDay2022
@StopSarcoidosis
0
4
12